<DOC>
	<DOCNO>NCT00430326</DOCNO>
	<brief_summary>This trial undertaken investigate efficacy safety Juvista improvement scar appearance administer approximate wound margin follow varicose vein surgery . The result trial use select dose investigation future clinical trial compound .</brief_summary>
	<brief_title>Juvista ( Avotermin ) Scars Following Varicose Vein Removal</brief_title>
	<detailed_description>Patients undergoing bilateral removal saphenous vein ( ligation strip ) invite participate study . Consenting patient undergo detailed screening examination , suitability progress randomisation study confirm . Suitable screened patient attend schedule surgery vein removal normal - termed `` Day 0 '' At time wound closure , IMP administer via intra-dermal injection incisional groin wound , exit wound . Each patient serve control one leg administer active IMP ( either 5 , 50 , 200 500ng/100 ul ) dose solution , whilst leg administer placebo solution . The study double-blinded , neither Investigator patient know leg wound receive treatment . Further Day 0 , patient request attend 5 follow visit ( Week 6 , Month 3 , Month 5 , Month 7 &amp; Month 12 ) , photographs scar take , together spectrophotometry reading measure colour scar . At visit , Investigator patient rate opinion scar , global assessment scale &amp; VAS , together patient complete questionnaire .</detailed_description>
	<mesh_term>Varicose Veins</mesh_term>
	<mesh_term>Cicatrix</mesh_term>
	<criteria>Male female patient 18 85 year age . Patients undergo surgical removal bilateral varicose vein ligation stripping , result clinically similar ( i.e . size location ) wound groin knee . Patients provide write informed consent . Patients body mass index 15 35 kg/m2 inclusive . Patients , opinion Investigator , clinically acceptable result laboratory test specify trial protocol ( see Protocol Section 6.4.1 ) . Female patient child bear potential use method ( ) contraception acceptable Investigator agree least screening visit one month administration Investigational Medicinal Product . Patients previous surgical treatment varicose vein . Patients history bleed disorder . Patients chronic currently active skin disorder may adversely affect heal acute wound involve area examine trial . Patients direct question and/or physical examination , evidence past present clinically significant medical condition would impair wound heal . Patients take take investigational drug 3 month prior screen visit . Patients exist scar within 3cm potential trial wound . Patients diseases condition could , opinion Investigator , interfere assessment safety , tolerability efficacy Investigational Product . Patients history clinically significant hypersensitivity drug surgical dressing use trial . Patients take regular , continuous , oral corticosteroid therapy . Patients undergoing investigation change management exist medical condition . Patients pregnant lactate . Patients , opinion Investigator , likely complete trial .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>March 2010</verification_date>
</DOC>